neoSurgical Inc. has begun a postmarket surveillance study of its FDA-cleared device, neoClose, at University of Texas Health Sciences Center at Houston. The randomized study will compare neoClose against the standard of care for closure in a bariatric surgery gastric...
READ MORE




